Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FY8XW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,772
Award facts
- Contract value 100% obligated
- $4,771.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,771.86 on August 6, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, completed under competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supplier particularly for military and veteran healthcare systems. The underlying IDC functions as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor program utilizes such contract vehicles to ensure reliable access to essential medications and medical commodities supporting the federal health enterprise.
Quick answers
Who was awarded contract SPE2DB25FY8XW?
SPE2DB25FY8XW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FY8XW worth?
The government has obligated $4,772 on SPE2DB25FY8XW.
Is contract SPE2DB25FY8XW an order under another contract?
Yes. SPE2DB25FY8XW is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8XW competed?
The extent of competition for SPE2DB25FY8XW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award